Page last updated: 2024-11-03

ono 1078 and Nerve Degeneration

ono 1078 has been researched along with Nerve Degeneration in 2 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research Excerpts

ExcerptRelevanceReference
"Oral montelukast (0."1.37Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. ( Fang, SH; Shi, WZ; Wei, EQ; Zhang, YM; Zhao, R, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, R1
Shi, WZ1
Zhang, YM1
Fang, SH2
Wei, EQ2
Zhou, Y1
Wang, ML1
Zhang, WP1
Yu, GL1
Chu, LS1
Chen, Z1

Other Studies

2 other studies available for ono 1078 and Nerve Degeneration

ArticleYear
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:4

    Topics: Acetates; Administration, Oral; Animals; Antipyrine; Atrophy; Behavior, Animal; Brain Injury, Chroni

2011
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
    Neuroscience, 2006, Jul-07, Volume: 140, Issue:3

    Topics: Animals; Astrocytes; Brain Ischemia; Cerebral Infarction; Chromones; Disease Models, Animal; Encepha

2006